title: [Liver transplantation increases R0 resection and survival of patients with a non-disseminated unresectable Klatskin tumour].
abstract: BACKGROUND
  There are no established indications for Liver transplant (LT) in patients with a Klatskin tumour (KT) due to the differences in the published results.
  
  
  OBJECTIVE
  To report on our patients who have non-disseminated unresectable KT and who were given a LT, and to compare results with those of patients who have had tumour resection and those who have not.
  
  
  METHODS
  We have treated 75 patients diagnosed with KT. The mean age was 62 + or - 11 years (range: 38-88 years) and 50 were males (66%). Twenty patients were inoperable. Of the 55 patients who underwent surgery: tumour resection (TR) was performed in 29 cases; there was no tumour dissemination in 11 unresectable cases and therefore these patients were added to the LT waiting list and the remaining 15 unresectable cases had tumour dissemination and remained on palliative treatment.
  
  
  RESULTS
  In the LT group there was no postoperative mortality (during the first month) and the survival rate was 95%, 59% and 36% with a disease-free survival of 75%, 40% and 20%; whereas the patients given RT had a survival rate of 80%, 52% and 38% at 1, 3 and 5 years, with a disease-free survival of 65%, 35% and 19%, without any differences compared to the LT group. Patients with unresectable tumour left on palliative therapy had a lower survival than the unresectable who underwent LT (p<0.001).
  
  
  CONCLUSIONS
  In patients with non-disseminated unresectable KT, LT has a similar survival to that obtained in cases with resectable R0 liver resection. LT improves the survival rate achieved using palliative treatment in patients with non-disseminated unresectable KT.
authors.affiliation: Unidad de Cirugía Hepática y Trasplante Hepático, Departamento de Cirugía, Hospital Universitario Virgen de la Arrixaca, Murcia, España. rirocam@um.es
authors.forename: Ricardo
authors.initials: R
authors.lastname: Robles
authors.forename: Pascual
authors.initials: P
authors.lastname: Parrilla
authors.forename: Pablo
authors.initials: P
authors.lastname: Ramírez
authors.forename: Francisco
authors.initials: F
authors.lastname: Sánchez-Bueno
authors.forename: Caridad
authors.initials: C
authors.lastname: Marín
authors.forename: Patricia
authors.initials: P
authors.lastname: Pastor
authors.forename: José Antonio
authors.initials: JA
authors.lastname: Pons
authors.forename: Francisco
authors.initials: F
authors.lastname: Acosta
authors.forename: Domingo
authors.initials: D
authors.lastname: Pérez-Flores
authors.forename: Jesús
authors.initials: J
authors.lastname: De La Peña Morales
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001650:Bile Duct Neoplasms / Q000401:mortality* / Q000601:surgery*; D005260:Female; D006500:Hepatic Duct, Common; D006801:Humans; D018285:Klatskin Tumor / Q000401:mortality* / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D015996:Survival Rate